MR: Iyaku Joho Tantosha (2026)

Kionaka Masaki, the manager of the Third Sales Office at the Tokyo branch of the mid-sized pharmaceutical company Tenpo Pharmaceuticals, is also a medical representative (MR). He is determined to secure a coveted position for the company’s groundbreaking new Type 2 diabetes drug, Pancel, as a first-line treatment (Grade A recommendation) in the official medical treatment guidelines. Being selected as a first-line treatment would virtually guarantee that the drug becomes a blockbuster product with annual sales exceeding 100 billion yen. However, fierce interference from Samejima Jun, an MR working for the rival multinational pharmaceutical company Taurus, suddenly places Pancel under scrutiny for alleged compliance violations during a seminar, jeopardizing its promising future. At the same time, it comes to light that Novelma, a cancer treatment drug produced by Tenpo Pharmaceuticals and personally recommended by Kionaka to patients, has been linked to fatal side effects. As the company faces the threat of a major pharmaceutical liability lawsuit, divisions begin to emerge within the organization itself. With both Kionaka and Tenpo Pharmaceuticals pushed into an increasingly desperate situation, the story explores the question: Who should medicine truly serve, and what should its purpose be? (Source: Japanese = WOWOW || Translation = MyDramaList) ~~ Adapted from the novel "MR" by Kusakabe Yo (久坂部羊). Edit Translation

• English
• Español
• Português (Brasil)
• 한국어